Finance

Lists
FAGR:EBR
Fagron NV
€21.00
-0.47%
(-0.10) 1D
Sep 11, 5:38:28 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for FAGR...
Open
€21.05
High
€21.25
Low
€20.85
Mkt. cap
1.53B
Avg. vol.
93.62K
Volume
96.30K
Dividend
1.33%
Quarterly dividend
€0.07
Ex-dividend date
May 18, 2026
P/E ratio
16.80
52-wk high
€25.30
52-wk low
€19.24
EPS
€1.25
Shares outstanding
73.77M
No. of employees
5K
Open
€21.05
High
€21.25
Low
€20.85
Mkt. cap
1.53B
Avg. vol.
93.62K
Volume
96.30K
Dividend
1.33%
Quarterly dividend
€0.07
Ex-dividend date
May 18, 2026
P/E ratio
16.80
52-wk high
€25.30
52-wk low
€19.24
EPS
€1.25
Shares outstanding
73.77M
No. of employees
5K
Profile
Fagron NV is a publicly traded multinational group of companies governed by Belgian law. Its registered office is located in Waregem, Belgium, and its headquarters is located at Rotterdam, Netherlands. Founded as Arseus NV, it was formerly the Professional Health Division of Omega Pharma, and became an independent entity via an IPO on October 5, 2007 and has been listed on Euronext Brussels and Euronext Amsterdam since then. Its share is included in the BEL MID-index and the Amsterdam Small Cap Index. The head office of Fagron is located in Rotterdam. Wikipedia
About Fagron NV
CEORafael Padilla
Employees4.88K
Founded1990
Headquarters-
SectorHealth care provider
Websitefagron.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
238.02M
238.02M
276.24M
276.24M
Cost of goods sold
130.74M
130.74M
155.20M
155.20M
Cost of revenue
130.74M
130.74M
155.20M
155.20M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
58.85M
58.85M
67.70M
67.70M
Operating expense
71.39M
71.39M
83.13M
83.13M
Total operating expenses
202.14M
202.14M
238.34M
238.34M
Operating income
35.88M
35.88M
37.90M
37.90M
Other non operating income
-2.10M
-2.10M
-1.70M
-1.70M
EBT including unusual items
29.27M
29.27M
29.00M
29.00M
EBT excluding unusual items
28.65M
28.65M
29.00M
29.00M
Income tax expense
6.40M
6.40M
5.73M
5.73M
Effective tax rate
21.86%
21.86%
19.77%
19.77%
Other operating expenses
810.00K
810.00K
784.50K
784.50K
Net income
22.73M
22.73M
23.14M
23.14M
Net profit margin
9.55%
9.55%
8.38%
8.38%
Earnings per share
-
-
-
-
Interest and investment income
1.16M
1.16M
1.15M
1.15M
Interest expense
-5.28M
-5.28M
-8.03M
-8.03M
Net interest expenses
-4.12M
-4.12M
-6.88M
-6.88M
Depreciation and amortization charges
11.74M
11.74M
14.65M
14.65M
EBITDA
40.01M
40.01M
47.29M
47.29M
Gain or loss from assets sale
-140.50K
-140.50K
-119.50K
-119.50K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps